How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research Trinity Biotech USA in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
11 clearance records and 2 recall records in the covered releases, across 1 source company names and 11 product codes. Dated history runs from Nov 26, 1999 to Jul 22, 2025.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| Bartels ELISA Legionella Urinary Antigen. Model Number: B1029-440. In Vitro Diagnostic test kit for the presumptive diagnosis of past or current…Z-2292-2025 · MJH | Trinity Biotech USA | Recall | Aug 12, 2025FDA classification date |
| CAPTIA MEASLES IGMK140455 · PCL | Trinity Biotech USA | 510(k) | May 22, 2014FDA decision date |
| AMAX ThromboMAX with Calcium, 10x4ml vials. Catalog #T9902. Lyophilized extract of rabbit brain with buffer, stabilizers and calcium chloride. …Z-0261-05 · GJS | Trinity Biotech USA | Recall | Nov 30, 2004FDA classification date |
| CAPTIA HSV 1 IGG TYPE SPECIFIC ELISA KITK033105 · MXJ | Trinity Biotech USA | 510(k) | Jul 13, 2004FDA decision date |
| CAPTIA HSV 2 IGG TYPE SPECIFIC ELISA KITK033106 · MYF | Trinity Biotech USA | 510(k) | Jul 13, 2004FDA decision date |
| LEGIONELLA PNEUMOPHILA IGG/IGMK033051 · MJH | Trinity Biotech USA | 510(k) | Nov 26, 2003FDA decision date |
| MYCOPLASMA IGGK033064 · LON | Trinity Biotech USA | 510(k) | Nov 26, 2003FDA decision date |
| PYLORI IGGK033067 · LYR | Trinity Biotech USA | 510(k) | Nov 26, 2003FDA decision date |
| BORRELIA BURGDORFERI IGM ELISA TEST SYSTEMK033070 · LSR | Trinity Biotech USA | 510(k) | Nov 26, 2003FDA decision date |
| CHLAMYDIA IGG ELISA TEST SYSTEMK033079 · LJC | Trinity Biotech USA | 510(k) | Nov 26, 2003FDA decision date |
| BORRELIA BURGDORFERI IGG/IGM ELISA TEST SYSTEMK033083 · LSR | Trinity Biotech USA | 510(k) | Nov 26, 2003FDA decision date |
| ENA PROFILE ELISA TEST SYSTEMK993839 · LLL | Trinity Biotech USA | 510(k) | Jan 12, 2000FDA decision date |
| MACRA LP(A) ENZYME IMMUNOASSAY KITK992665 · DFC | Trinity Biotech USA | 510(k) | Nov 26, 1999FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.